NCT04523844View on ClinicalTrials.gov

Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

July 30, 2020

Conditions
Eye DiseasesInjection ComplicationIntraocular Pressure
Interventions
DRUG

Brinzolamide-brimonidine Fixed Combination

In case group one drop of a fixed combination of brinzolamide-brimonidine will be instilled two hours before the injection

Trial Locations (1)

11522

"Elpis General Hospital", Athens

All Listed Sponsors
lead

General Hospital of Athens Elpis

OTHER

NCT04523844 - Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections | Biotech Hunter | Biotech Hunter